Cerespir
41 Madison Avenue, 25th Floor
New York
New York
10010
United States
Website: http://www.cerespir.com/
8 articles about Cerespir
-
CERESPIR INCORPORATED Assembles World Class Clinical Advisory Board Chaired by Professor Robert A. Hauser to Support CERESPIR's Parkinson's Disease Development Program for Itanapraced
3/26/2019
CERESPIR INCORPORATED announced the formation of an expanded Clinical Advisory Board to support Phase 2 clinical development of its lead compound itanapraced in Parkinson's disease.
-
Cerespir Obtains New Patent From USPTO Covering The Optimal Synthetic Route For Commercial Manufacture Of CSP-1103 In Late Stage Development To Slow The Progression Of Mild Cognitive Impairment Due To Alzheimer's Disease
7/14/2015
-
Cerespir Submits Special Protocol Assessment Request To FDA For A Phase III Clinical Trial To Test The Ability Of CSP-1103 To Slow The Progression Of Mild Cognitive Impairment Due To Alzheimer's Disease
7/1/2015
-
Cerespir Appoints Sophie Egholm As Chief Operating Officer
4/30/2015
-
Cerespir Appoints Eric Karran, Ph.D., As Chairman Of Its Scientific Advisory Board
1/7/2015
-
Cerespir Appoints Adrian N. Hobden, Ph.D., As Chairman Of Its Board Of Directors
9/30/2014
-
Cerespir Announces The Inauguration Of Its Clinical Advisory Board
2/21/2014
-
Cerespir Announces Chris Griffett Will Serve As Vice President, Regulatory Affairs
1/10/2014